Patent · US Active

BCMA chimeric antigen receptors

US11633463B2 · kind B2 · utility

4Cited by
39References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 1, 2020
Grant dateApr 25, 2023
Priority date—
Expiry dateMar 11, 2041

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.